Indivior Pharmaceuticals (INDV) Treasury Shares (2022 - 2026)

Indivior Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 34.6% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (down 34.6% YoY), while the FY2025 annual figure was $5.0 million, up 379.54% from the prior year.
• Treasury Shares was $2.9 million for Q1 2026 at Indivior Pharmaceuticals, down from $5.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.5 million in Q2 2025 to a low of $1.0 million in Q4 2024.
• Historically, Treasury Shares has averaged $3.5 million across 5 years, with a median of $3.7 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares sank 80.56% in 2024, then soared 379.54% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.6 million in 2022, then jumped by 242.64% to $5.3 million in 2023, then tumbled by 80.56% to $1.0 million in 2024, then jumped by 379.54% to $5.0 million in 2025, then slumped by 41.3% to $2.9 million in 2026.
• The last three Treasury Shares figures came in at $2.9 million (Q1 2026), $5.0 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.